Wang Qiang, Li Yujiang, Zheng Liyun, Huang Xiaowan, Wang Yanli, Chen Chin-Ho, Cheng Yung-Yi, Morris-Natschke Susan L, Lee Kuo-Hsiung
High & New Technology Research Center of Henan Academy of Sciences, Zhengzhou 450002, China.
National Health Commission Key Laboratory of Birth Defect Prevention, Zhengzhou 450002, China.
ACS Med Chem Lett. 2020 Sep 9;11(11):2290-2293. doi: 10.1021/acsmedchemlett.0c00414. eCollection 2020 Nov 12.
Novel betulinic/betulonic acid-nucleoside hybrids were synthesized as possible new anti-HIV agents. Among the synthesized hybrids, two compounds were highly effective against HIV. Compared with AZT and DSB, compounds (IC = 0.0078 μM, CC = 9.6 μM) and (IC = 0.020 μM, CC = 23.8 μM) showed more potent or equipotent, respectively, anti-HIV activity but displayed lower cytotoxicity.
合成了新型桦木酸/桦木酮酸-核苷杂合物作为可能的新型抗HIV药物。在合成的杂合物中,有两种化合物对HIV具有高效性。与齐多夫定(AZT)和双脱氧双氢胸苷(DSB)相比,化合物(IC = 0.0078 μM,CC = 9.6 μM)和(IC = 0.020 μM,CC = 23.8 μM)分别显示出更强或相当的抗HIV活性,但细胞毒性较低。